Intraoperative high-dose-rate brachytherapy for pediatric solid tumors: A 10-year experience Academic Article Article uri icon

Overview

MeSH Major

  • Prostatic Neoplasms

abstract

  • IOHDR is emerging as an integral part of multimodality therapy for pediatric solid tumors as an adjunct to EBRT for local control. IOHDR alone may not be appropriate in the majority of patients. Subacute toxicities occurred rarely and may be related to the combination of extensive surgery, EBRT, and multi-agent chemotherapy in this population.

publication date

  • October 13, 2003

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/S1538-4721(03)00135-1

PubMed ID

  • 15062136

Additional Document Info

start page

  • 139

end page

  • 46

volume

  • 2

number

  • 3